Exspore
90/100
This product looks safe
- Contains proprietary blend — exact ingredient amounts not disclosed
- 40% of ingredients have research evidence
A
Label Compliance Grade
Product Label
Have a supplement label? Find it here.
Upload a photo of any supplement label to search our database of 92,312 products.
Safety Alerts
ℹ️ Contains proprietary blend — exact ingredient amounts not disclosed
Label Data
1 Tablet(s)
Serving Size
Other Combinations
Product Type
40%
Evidence Coverage
Supplement Facts — Evidence Check
2.5 mg
(13% DV)
✅ Within RDA (0.2× RDA of 14 mg)
📚 193 studies (Tier A: 5, B: 63)
5 mg
(33% DV)
✅ Within RDA (0.5× RDA of 11 mg)
📚 258 studies (Tier A: 6, B: 134)
1 mg
(50% DV)
✅ Within RDA (0.4× RDA of 2.3 mg)
📚 8 studies — no high-quality reviews
25 mcg
(33% DV)
✅ Within RDA (0.6× RDA of 0.045 mg)
📚 2 studies — no high-quality reviews
Proprietary Blend
374.72 mg
Other Ingredients
Dicalcium Phosphate
Stearic Acid
Magnesium Stearate
Label Claims — Verification
❓
All Other
All Other (97% of products)
Structure/Function (86% of products)
Nutrient (36% of products)
Target Groups
Adult (18 - 50 Years)
Product Information
⚠️ Warnings & Precautions
Keep out of reach of children.
Tamper resistant outer seal – do not use if broken.
Additional Information
For distribution by health care professionals only.
Store in a cool, dry place.
“When you want the best”
Product Details
DSLD Entry Date
2020-02-26
Product Type
Other Combinations
Form
Tablet or Pill
Brand
Nutri-West
DSLD ID
214608
Data Updated
2026-04-11
Research Evidence
241
Research Sources
55
Avg Quality Score
113
Meta Analysis
75
Systematic Review
32
Rct
11
Clinical Trial
3
Other
3
Regulatory Source
1
Cochrane Review
1
Narrative Review
1
Openfda Safety
A
Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases
A
Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117,411 patients
A
A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk
A
Topical azelaic acid, salicylic acid, nicotinamide, sulphur, zinc and fruit acid (alpha-hydroxy acid) for acne
B
Assessment of the Role of Niacin in Managing Cardiovascular Disease Outcomes: A Systematic Review and Meta-analysis
Compare Similar Products
Rezistaf
LifeLink
100
Coenzymated B-3 25 mg
Source Naturals
100
Vitamin B Complex
Simply Supplements
100
Test X180 Boost
Force Factor
100
8-Hour Alert
MHP Maximum Human Performance
100